201 related articles for article (PubMed ID: 28212922)
41. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
[TBL] [Abstract][Full Text] [Related]
42. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus.
Wu GC; Li J; Leng RX; Li XP; Li XM; Wang DG; Pan HF; Ye DQ
Oncotarget; 2017 Apr; 8(14):23650-23663. PubMed ID: 28423570
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of systemic lupus erythematosus activity during pregnancy].
Olesińska M; Wiesik-Szewczyk E; Chwalińska-Sadowska H
Pol Arch Med Wewn; 2007 Jul; 117(7):312-6. PubMed ID: 17966597
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers.
Duroux-Richard I; Cuenca J; Ponsolles C; Piñeiro AB; Gonzalez F; Roubert C; Areny R; Chea R; Pefaur J; Pers YM; Figueroa FE; Jorgensen C; Khoury M; Apparailly F
Int J Mol Sci; 2015 Jul; 16(8):16953-65. PubMed ID: 26225955
[TBL] [Abstract][Full Text] [Related]
45. Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Drucker AM; Su J; Mussani F; Siddha SK; Gladman DD; Urowitz MB
Lupus; 2016 Apr; 25(4):376-81. PubMed ID: 26453664
[TBL] [Abstract][Full Text] [Related]
46. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
[TBL] [Abstract][Full Text] [Related]
47. Systemic lupus erythematosus.
Manson JJ; Rahman A
Orphanet J Rare Dis; 2006 Mar; 1():6. PubMed ID: 16722594
[TBL] [Abstract][Full Text] [Related]
48. Disease characterization of systemic lupus erythematosus (SLE) patients in Quebec.
Ng R; Bernatsky S; Rahme E
Lupus; 2017 Aug; 26(9):1005-1011. PubMed ID: 28178878
[TBL] [Abstract][Full Text] [Related]
49. Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry.
Ferreira TAR; de Andrade HM; de Pádua PM; Carvalho MDG; Pires SDF; Oliveira IHR; Lima BSS; Fialho Júnior LC; Cicarini WB; Chapeourouge DA; Perales JH; Guimarães TMPD; Toledo VPCP
Autoimmunity; 2017 Jun; 50(4):247-256. PubMed ID: 28675715
[TBL] [Abstract][Full Text] [Related]
50. Biomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic review.
Nicolaou O; Kousios A; Hadjisavvas A; Lauwerys B; Sokratous K; Kyriacou K
J Cell Mol Med; 2017 May; 21(5):993-1012. PubMed ID: 27878954
[TBL] [Abstract][Full Text] [Related]
51. Biomarkers for systemic lupus erythematosus.
Ahearn JM; Liu CC; Kao AH; Manzi S
Transl Res; 2012 Apr; 159(4):326-42. PubMed ID: 22424435
[TBL] [Abstract][Full Text] [Related]
52. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
[TBL] [Abstract][Full Text] [Related]
53. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
Joo YB; Bae SC
Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
[TBL] [Abstract][Full Text] [Related]
54. Promising biomarkers for systemic lupus erythematosus.
Jung JY; Bae CB; Suh CH
Expert Opin Med Diagn; 2013 Nov; 7(6):601-13. PubMed ID: 24099307
[TBL] [Abstract][Full Text] [Related]
55. Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients.
Mosaad NA; Lotfy HM; Farag YM; Mahfouz RH; Shahin RM
Immunol Lett; 2017 Jan; 181():16-19. PubMed ID: 27838471
[TBL] [Abstract][Full Text] [Related]
56. The role of biomarkers in the assessment of lupus.
Merrill JT; Buyon JP
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):709-26. PubMed ID: 16150399
[TBL] [Abstract][Full Text] [Related]
57. Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.
Pons-Estel GJ; Aspey LD; Bao G; Pons-Estel BA; Wojdyla D; Saurit V; Alvarellos A; Caeiro F; Haye Salinas MJ; Sato EI; Soriano ER; Costallat LT; Neira O; Iglesias-Gamarra A; Reyes-Llerena G; Cardiel MH; Acevedo-Vásquez EM; Chacón-Díaz R; Drenkard C
Lupus; 2017 Jan; 26(1):73-83. PubMed ID: 27230554
[TBL] [Abstract][Full Text] [Related]
58. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
59. Biologics in SLE: the current status.
Rajadhyaksha AG; Mehra S; Nadkar MY
J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
[TBL] [Abstract][Full Text] [Related]
60. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
